Invitrogen Looks To Limit Damages From Patent Suit
Life sciences company Invitrogen Corp. on Tuesday filed a motion that seeks to limit the potential damages in a lawsuit that accuses it of infringing a patent related to the introduction...To view the full article, register now.
Already a subscriber? Click here to view full article